v3.26.3
Subsequent Events (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Oct. 15, 2026
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2026
Dec. 31, 2025
Aug. 26, 2026
Aug. 01, 2026
Dec. 30, 2025
Dec. 31, 2024
Subsequent Event [Line Items]                  
Common Stock, Par or Stated Value Per Share   $ 0.0001   $ 0.0001 $ 0.0001       $ 0.0001
Common Stock, Shares, Issued   1,663,280   1,663,280 1,269,286       1,161,983
Reduction In Workforce       70.00% 30.00%        
Standby Equity Purchase Agreement [Member]                  
Subsequent Event [Line Items]                  
Common Stock, Shares, Issued         4,868     4,868  
Proceeds from Issuance of Common Stock   $ 0.0   $ 400,000          
Subsequent Event [Member]                  
Subsequent Event [Line Items]                  
Outstanding pre paid advance amount convertible into common stock         $ 4,500,000        
Common Stock, Shares, Issued     48,092            
Proceeds from Issuance of Common Stock     $ 400,000            
Reduction In Workforce         70.00%        
Subsequent Event [Member] | Yorkville [Member]                  
Subsequent Event [Line Items]                  
Commitment Fee Amount $ 500,000                
Subsequent Event [Member] | Common Stock [Member]                  
Subsequent Event [Line Items]                  
Common Stock, Par or Stated Value Per Share           $ 0.0001      
Subsequent Event [Member] | Common Stock [Member] | Standby Equity Purchase Agreement [Member] | Yorkville [Member]                  
Subsequent Event [Line Items]                  
Common Stock, Par or Stated Value Per Share $ 0.0001                
Sale Of Stock Maximum Commitment Amount $ 40,000.0                
Subsequent Event, Description On October 15, 2026, in connection with entering into the 2026 SEPA described above, the Company terminated the SEPA dated as of November 20, 2025 (the “Prior SEPA”), between the Company and Yorkville. Pursuant to the Prior SEPA, the Company had the right, but not the obligation, to sell to Yorkville up to $15.0 million of shares of Common Stock. Prior to its termination, the Company sold an aggregate of 48,092 shares of Common Stock to Yorkville under the Prior SEPA for aggregate gross proceeds of approximately $0.4 million.                
Context Therapeutics Inc [Member] | Subsequent Event [Member]                  
Subsequent Event [Line Items]                  
Amended License Agreement Payment Received             $ 2,000,000.0